The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

Male Contraceptive Initiative & IMPT: CT/MPT Fellowship Promotional Webinar

The IMPT, Male Contraceptive Initiative, Logan Nickels, Leigh Allen, Paul Webster, Heather Vahdat, Bethany Young Holt February 2023
Sexually Transmitted Infections: Public Health Status and Opportunities for Multipurpose Prevention Technologies

Sexually Transmitted Infections: Public Health Status and Opportunities for Multipurpose Prevention Technologies

The IMPT, James Cummins, Ina Park, Katherine Yang, Bethany Young Holt January 2023
Considerations when Transitioning an MPT Product Candidate from Preclinical to Clinical Development

Considerations when Transitioning an MPT Product Candidate from Preclinical to Clinical Development

The IMPT, Meredith Clark, Ruth Merkatz, Nyaradzo Mgodi, Jim Turpin, Ariane van der Straten, Bethany Young Holt September 2022
Patenting and Intellectual Property Considerations for HIV Prevention & MPTs

Patenting and Intellectual Property Considerations for HIV Prevention & MPTs

The IMPT, Ian McGowan, Nataliya Omelchuk, Akash Bakshi June 2022
Integrating End-User Research in MPT Product Development & Commercialization Strategies

Integrating End-User Research in MPT Product Development & Commercialization Strategies

The IMPT, Moushira El-Sahn, Andrea Thurman, Liz Pinto, Karina Fedasz May 2022
MPT Regulatory Pathways: Case Studies From MPT Product Developers

MPT Regulatory Pathways: Case Studies From MPT Product Developers

The IMPT, Mary Weitzel, Daniel Loeven, Wilberto Robles February 2022
Can Fantasies Become Realities? The Quest for Multipurpose Prevention Products

Can Fantasies Become Realities? The Quest for Multipurpose Prevention Products

AIDS Foundation of Chicago (AFC) & AVAC October 2021
New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies

New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies

The IMPT, California Prevention Training Center (CAPTC), Dr. Ina Park, Dr. Bethany Young Holt June 2021
Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches

Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches

The IMPT, Rahima Benhabbour, Courtney Jarrahian, Joseph Romano June 2021
Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations

Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations

The IMPT, Certara, Deven Shah, Kevin Hershberger, Tamra Goodrow June 2021
Toxicity study considerations for HIV prevention and MPT R&D

Toxicity study considerations for HIV prevention and MPT R&D

The IMPT, Thomas Moench, Miles Brennan May 2021
Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned

Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned

The IMPT, Deborah Anderson, Mary Weitzel, Betsy Tolley, Matthew Quaife, Khatija Ahmed, Joseph Murungu, Bethany Young Holt March 2021
The role of cervicovaginal microbiota on contraceptive and MPT development

The role of cervicovaginal microbiota on contraceptive and MPT development

The IMPT, Jacques Ravel, Jennifer Deese December 2020
Opportunities and Challenges for Long-Acting MPTs

Opportunities and Challenges for Long-Acting MPTs

Opportunities and Challenges for Long-Acting MPTs 02 May 2018 This is a live webinar featuring Dr. Charles Flexner (Johns Hopkins Medicine) who discusses employing long-acting delivery methods to develop an MPT with an HIV perspective and Dr. Arnab Chatterjee (California Institute for Biomedical Research, Calibr) who discusses defining and developing drug substances as relevant to […]

Flexner, C. & Chatterjee, A. May 2018
Contraceptive Method Use and Chlamydia Positivity

Contraceptive Method Use and Chlamydia Positivity

Contraceptive Method Use and Chlamydia Positivity 23 January 2018 This live webinar featured Lauren Hunter, a doctoral student at UC Berkeley, presenting an analysis comparing chlamydia positivity by type of contraceptive method used among women tested through California’s Family PACT program in 2012-2013, and provides a platform to recommend further advancement of MPTs that adequately […]

Hunter, L., ASHWG January 2018
Driving Impactful End-User Research for More Insightful MPT Development

Driving Impactful End-User Research for More Insightful MPT Development

Driving Impactful End-User Research for More Insightful MPT Development 12 December 2017 This live webinar aimed to engage new stakeholders brings experts together for a dynamic discussion of lessons from conducting end-user research in the fields of contraception, HIV, and MPTs to synthesize and share best practices for MPT product development and introduction. The webinar […]

Lin, A., Gomez, A., Guthrie, K., Tolley, B. December 2017
MPT End-User Research: Updates from the Field

MPT End-User Research: Updates from the Field

MPT End-User Research: Updates from the Field 28 September 2017 This live webinar highlighted new research exploring the acceptability of and preference between potential MPT product types, drivers of future product use, and other important end-user considerations. It featured presentations from Moushira El-Sahn and Jeff Lucas (Routes-2-Results), Barbara Friedland (Population Council), and Alexandra Minnis (RTI […]

El-Sahn, M., Lucas, J., Friedland, B., Minnis, A. September 2017
Modelling the Potential of MPTs: Current Landscape and Challenges

Modelling the Potential of MPTs: Current Landscape and Challenges

Modelling the Potential of MPTs: Current Landscape and Challenges 04 May 2017 This live webinar explored the current landscape of MPT modelling around public health impact, cost-effectiveness, uptake, and other forecasting. The webinar featured a presentation by Dr. Íde Cremin (Imperial College London) around her team’s complex model of the health impact and cost effectiveness […]

Cremin, I., Dellplain, L., Polis, C., Quaife, M. May 2017
Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks

Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks

Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks 26 January 2017 click to view Blog In this Blog :

DiLiberti,C., Dorflinger, L., Romano, J. January 2017
Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV 08 March 2016 This panel session provided an overview of recent data on various hormonal contraceptive methods and HIV acquisition in HIV-negative women and gave an update of current evidence on drug interactions between various contraceptive hormones and specific […]

Vogelsong, K., Polis, C., Hemmerling, A., & Dellplain, L. March 2016
Exploring Dapivirine Ring Results

Exploring Dapivirine Ring Results

Exploring Dapivirine Ring Results 01 March 2016 click to view Webinar In this Webinar: Health Risk(s): HIV STI / STD Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): MPTs Product Development Product Trials

Baeten, J., & Rosenberg, Z. Visit Webinar March 2016
Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy

Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy

Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy 21 October 2015 This webinar presented highlights from the MPT panel session at the 2015 ISSTDR World STI & HIV Congress in Brisbane, Australia, co-sponsored by the World Health Organization (WHO), the University of California San Francisco (UCSF) Bixby Center for Global […]

Hemmerling, A., Schelar, E., Mmeje, O., & Young Holt, B. October 2015
Latin America and the Caribbean (LAC) Regional Webinar on MPTs

Latin America and the Caribbean (LAC) Regional Webinar on MPTs

Latin America and the Caribbean (LAC) Regional Webinar on MPTs 13 May 2015 The LAC Regional webinar on MPTs provided a general overview of MPTs, and contextualized the need for MPTs within regional epidemiological data and the social realities faced by LAC women. It served as an initial step in engaging LAC-based sexual and reproductive […]

Townsend, J. & Cole, K., & Dinev, M. May 2015
After FACTS: What’s next for HIV prevention in women?

After FACTS: What’s next for HIV prevention in women?

After FACTS: What’s next for HIV prevention in women? 09 March 2015 click to view Webinar In this Webinar: Health Risk(s): HIV Product Type(s): Vaginal Cream/Gel Topic(s): Product Trials

AVAC. Visit Webinar March 2015
MPT Acceptability in Uganda, Nigeria and South Africa

MPT Acceptability in Uganda, Nigeria and South Africa

MPT Acceptability in Uganda, Nigeria and South Africa 12 November 2014 This webinar summarized methods and key findings from the market research study conducted by Ipsos Healthcare, with support from the Bill & Melinda Gates Foundation, to assess the acceptability of MPTs among women in Uganda, Nigeria and South Africa. The key objectives of this […]

El-Sahn, M. & Lucas, J. November 2014
Multipurpose Prevention Technology (MPT) Manufacturing Issues

Multipurpose Prevention Technology (MPT) Manufacturing Issues

Multipurpose Prevention Technology (MPT) Manufacturing Issues 26 September 2014 In this live webinar, Dr. Joseph Romano (NWJ Group/IMPT), Kenneth Stockholm (Q Pharma), and Robert Russell (RJR Consulting) review CMO perspectives, cost of MPT product development and marketing, scalability, and more. • View Presentation • View Webinar Recording Romano, J., Stockholm, K., & Russell, R. In […]

Romano, J., Stockholm, K., & Russell, R. September 2014
MPT Product Development & Regulatory Issues 101

MPT Product Development & Regulatory Issues 101

MPT Product Development & Regulatory Issues 101 28 January 2014 In this live webinar, Dr. Joseph Romano (NWJ Group/IMPT) & Dr. Jim Turpin (NIAID) discuss the complexities of MPT development and a high-level discussion of current MPT candidates. • View Presentation • View Webinar Recording Romano, J. & Turpin, J. In this Webinar: Health Risk(s): […]

Romano, J. & Turpin, J. January 2014
Developing Technologies for Preventing Unintended Pregnancy & STIs

Developing Technologies for Preventing Unintended Pregnancy & STIs

Developing Technologies for Preventing Unintended Pregnancy & STIs 05 November 2013 Co-organized with ARHP, this CME/CE live webinar explored exciting developments in the MPT field and the global need for MPTs. Epidemiologic trends, end-user needs, and the rationale for MPTs Existing technologies for pregnancy and STI prevention Emerging MPTs and the expected timeline for product […]

Marrazzo, J. November 2013